IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

PEVERELLI, ERIKA MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.259
NA - Nord America 2.965
AS - Asia 1.975
SA - Sud America 196
AF - Africa 14
OC - Oceania 12
Totale 9.421
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.851
GB - Regno Unito 1.228
DE - Germania 1.124
CN - Cina 870
IT - Italia 594
SG - Singapore 430
SE - Svezia 392
HK - Hong Kong 232
RU - Federazione Russa 175
NL - Olanda 152
BR - Brasile 142
IN - India 134
FR - Francia 118
UA - Ucraina 96
CA - Canada 93
IE - Irlanda 83
FI - Finlandia 82
TR - Turchia 68
KR - Corea 55
ID - Indonesia 54
DK - Danimarca 51
JP - Giappone 41
ES - Italia 31
EU - Europa 26
BE - Belgio 25
VN - Vietnam 24
CO - Colombia 20
MX - Messico 17
AT - Austria 14
RO - Romania 14
CH - Svizzera 13
PL - Polonia 13
AR - Argentina 12
GR - Grecia 12
SK - Slovacchia (Repubblica Slovacca) 10
TW - Taiwan 8
AU - Australia 7
BD - Bangladesh 7
IL - Israele 7
EC - Ecuador 6
VE - Venezuela 6
NZ - Nuova Zelanda 5
PE - Perù 5
BO - Bolivia 4
BY - Bielorussia 4
CZ - Repubblica Ceca 4
EG - Egitto 4
IR - Iran 4
MY - Malesia 4
PK - Pakistan 4
SA - Arabia Saudita 4
SC - Seychelles 4
ZA - Sudafrica 4
KG - Kirghizistan 3
LU - Lussemburgo 3
PT - Portogallo 3
RS - Serbia 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
HR - Croazia 2
JO - Giordania 2
LB - Libano 2
LK - Sri Lanka 2
LT - Lituania 2
LV - Lettonia 2
MD - Moldavia 2
NO - Norvegia 2
PA - Panama 2
PH - Filippine 2
SV - El Salvador 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CL - Cile 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
HU - Ungheria 1
IQ - Iraq 1
MA - Marocco 1
MK - Macedonia 1
MM - Myanmar 1
OM - Oman 1
PS - Palestinian Territory 1
QA - Qatar 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
YE - Yemen 1
Totale 9.447
Salva come PNG Salva come JPEG
Città #
Southend 1.141
Hanover 676
Chandler 427
Singapore 273
Milan 247
Hong Kong 216
Ashburn 177
Ann Arbor 173
Seattle 155
Beijing 154
Houston 137
Frankfurt am Main 133
Wilmington 119
Santa Clara 117
Fairfield 115
Princeton 113
Council Bluffs 107
Dearborn 90
Dublin 82
Woodbridge 75
Nanjing 64
Toronto 64
Jacksonville 57
Bengaluru 50
Redwood City 47
Munich 46
Jinan 45
Hangzhou 39
Shanghai 39
Des Moines 38
New York 36
Boardman 35
Jakarta 34
Redmond 32
Serra 32
Cambridge 31
Grafing 31
Helsinki 29
Los Angeles 29
Berlin 27
Shenyang 26
Cangzhou 25
Mountain View 25
The Dalles 25
Brussels 21
Sunnyvale 21
Somerville 20
Bogotá 19
São Paulo 19
Zhengzhou 19
Padova 18
Sakarya 18
Tokyo 18
Andover 17
Guangzhou 17
Nanchang 17
Hebei 16
Istanbul 16
Nuremberg 16
Tianjin 16
Jiaxing 15
Phoenix 15
Columbus 14
Chicago 13
Changsha 11
San Diego 11
Amsterdam 10
Athens 10
Cinisello Balsamo 10
Rome 10
Bernolákovo 9
Bühl 9
Dallas 9
Hefei 9
Lauterbourg 9
London 9
Ottawa 9
Turin 9
Dong Ket 8
Fremont 8
Fuzhou 8
Haikou 8
Quanzhou 8
Seoul 8
Sevilla 8
Turku 8
Auburn Hills 7
Düsseldorf 7
Nürnberg 7
San Francisco 7
Taipei 7
Taizhou 7
Caserta 6
Edinburgh 6
Kunming 6
Pisa 6
Roubaix 6
Roxbury 6
Taiyuan 6
Vienna 6
Totale 6.266
Salva come PNG Salva come JPEG
Nome #
Pseudohypoparathyroidism and GNAS epigenetic defects : clinical evaluation of Albright hereditary osteodystrophy and molecular analysis in 40 patients 550
Cofilin is a cAMP effector in mediating actin cytoskeleton reorganization and steroidogenesis in mouse and human adrenocortical tumor cells 351
Cytoskeleton actin-binding proteins in clinical behavior of pituitary tumors 332
The cytoskeleton actin binding protein filamin A impairs both IGF2 mitogenic effects and the efficacy of IGF1R inhibitors in adrenocortical cancer cells 322
Genetic profiling of a cohort of Italian patients with ACTH-secreting pituitary tumors and characterization of a novel USP8 gene variant 322
β-arrestin 2 is required for dopamine receptor type 2 inhibitory effects on AKT phosphorylation and cell proliferation in pituitary tumors 298
A novel mechanism regulating dopamine receptor type 2 (DRD2) signal transduction in pituitary tumoral cells: the role of cAMP/PKA-induced filamin A (FLNA) phosphorylation 295
Octreotide and pasireotide effects on medullary thyroid carcinoma (MTC) cells growth, migration and invasion 250
Proliferation of transformed somatotroph cells related to low or absent expression of protein kinase a regulatory subunit 1A protein 239
Analysis of genetic variants of phosphodiesterase 11A (PDE11A) in acromegalic patients 216
The third intracellular loop of the human somatostatin receptor 5 is crucial for arrestin binding and receptor internalization after somatostatin stimulation 207
Peripheral insulin-like factor 3 concentrations are reduced in men with type 2 diabetes mellitus : effect of glycemic control and visceral adiposity on Leydig cell function 196
Somatostatin analogs regulate tumor corticotrophs growth by reducing ERK1/2 activity. 180
Specific roles of Gi protein family members revealed by dissecting SST5 coupling in human pituitary cells 178
PKA regulatory subunit R2B is required for murine and human adipocyte differentiation 176
Effect of cyclic adenosine 3',5'-monophosphate/protein kinase a pathway on markers of cell proliferation in nonfunctioning pituitary adenomas 174
Expression of the two alternatively spliced PRKAR1A RNAs in human endocrine glands 174
Dopamine and somatostatin analogues resistance of pituitary tumors : focus on cytoskeleton involvement 172
Quantitative analysis of methylation defects and correlation with clinical characteristics in patients with pseudohypoparathyroidism type I and GNAS epigenetic alterations 166
High expression of PKA regulatory subunit 1A protein is related to proliferation of human melanoma cells 164
Octreotide promotes apoptosis in human somatotroph tumor cells by activating somatostatin receptor type 2 161
Analysis of GNAS1 and PRKAR1A gene mutations in human cardiac myxomas not associated with multiple endocrine disorders 159
The third intracellular loop of the human somatostatin receptor 5 is crucial for arrestin binding and receptor internalisation after somatostatin stimulation 159
Dopamine receptor type 2 (DRD2) inhibits migration and invasion of human tumorous pituitary cells through ROCK-mediated cofilin inactivation 159
A novel pathway activated by somatostatin receptor type 2 (SST2): Inhibition of pituitary tumor cell migration and invasion through cytoskeleton protein recruitment 158
cAMP/PKA-induced filamin A (FLNA) phosphorylation inhibits SST2 signal transduction in GH-secreting pituitary tumor cells 158
Cofilin is a mediator of RET-promoted medullary thyroid carcinoma cell migration, invasion and proliferation. 144
Macroautophagy and the proteasome are differently involved in the degradation of alpha-synuclein wild type and mutated A30P in an in vitro inducible model (PC12/TetOn) 143
The dopamine-somatostatin chimeric compound BIM-23A760 exerts antiproliferative and cytotoxic effects in human non-functioning pituitary tumors by activating ERK1/2 and p38 pathways 142
Cyclic adenosine 3'-5'-monophosphate (cAMP) exerts proliferative and anti-proliferative effects in pituitary cells of different types by activating both cAMP-dependent protein kinase A (PKA) and exchange proteins directly activated by cAMP (Epac) 142
Dopamine receptor type 2 (DRD2) and somatostatin receptor type 2 (SSTR2) agonists are effective in inhibiting proliferation of progenitor/stem-like cells isolated from nonfunctioning pituitary tumors 140
Different expression of protein kinase A (PKA) regulatory subunits in cortisol-secreting adrenocortical tumors: Relationship with cell proliferation 139
Cytoskeleton protein Filamin A is required for efficient Somatostatin receptor type 2 internalization and recycling through Rab5 and Rab4 sorting endosomes in tumor somatotroph cells 136
Evaluation of proopiomelanocortin mRNA in the peripheral blood from patients with Cushing's syndrome of different origin 130
Stem Cells in Pituitary Tumors: Experimental Evidence Supporting Their Existence and Their Role in Tumor Clinical Behavior 124
Single-Molecule Microscopy Reveals Dynamic FLNA Interactions Governing SSTR2 Clustering and Internalization 123
Evolution of an aggressive prolactinoma into a growth hormone secreting pituitary tumor coincident with GNAS gene mutation 122
Drug resistance in pituitary tumours: from cell membrane to intracellular signalling 117
Autosomal Dominant Pseudohypoparathyroidism type Ib : a novel inherited deletion ablating STX16 causes Loss of Imprinting at the A/B DMR 114
Expression of protein kinase A regulatory subunits in benign and malignant human thyroid tissues : a systematic review 113
Characterization of intracellular signaling mediated by human somatostatin receptor 5 : role of the DRY motif and the third intracellular loop 112
DRD2 Agonist Cabergoline Abolished the Escape Mechanism Induced by mTOR Inhibitor Everolimus in Tumoral Pituitary Cells 111
HESX1 expression in human normal pituitaries and pituitary adenomas 109
cAMP effects in neuroendocrine tumors : the role of Epac and PKA in cell proliferation and adhesion 109
Filamin A in somatostatin and dopamine receptor regulation in pituitary and the role of cAMP/PKA dependent phosphorylation 105
Somatostatin Receptor Type 2 (SSTR2) Internalization and Intracellular Trafficking in Pituitary GH-Secreting Adenomas: Role of Scaffold Proteins and Implications for Pharmacological Resistance 103
Filamin A (FLNA) Plays an essential role in somatostatin receptor 2 (SST2) signaling and stabilization after agonist stimulation in human and rat somatotroph tumor cells 102
Protective effect of TAT-delivered alpha-synuclein: relevance of the C-terminal domain and involvement of HSP70 100
Filamin-A is essential for dopamine d2 receptor expression and signaling in tumorous lactotrophs 99
Identification of human somatostatin receptor 2 domains involved in internalization and signaling in QGP-1 pancreatic neuroendocrine tumor cell line 97
Deciphering the specific role of G(αi/o) isoforms: functional selective oxytocin ligands and somatostatin SST5 receptor mutants 96
Filamin-a is required to mediate SST2 effects in pancreatic neuroendocrine tumours 89
Somatostatin analogues increase AIP expression in somatotropinomas, irrespective of Gsp mutations 86
cAMP in the pituitary : an old messenger for multiple signals 85
Landscape of somatic mutations in sporadic GH-secreting pituitary adenomas 84
P720R USP8 Mutation Is Associated with a Better Responsiveness to Pasireotide in ACTH-Secreting PitNETs 76
The Novel SSTR3 Agonist ITF2984 Exerts Antimitotic and Proapoptotic Effects in Human Non-Functioning Pituitary Neuroendocrine Tumor (NF-PitNET) Cells 70
TMPRSS2 Expression and Activity Modulation by Sex-Related Hormones in Lung Calu-3 Cells: Impact on Gender-Specific SARS-CoV-2 Infection 67
Dimerization of GPCRs: Novel insight into the role of FLNA and SSAs regulating SST2 and SST5 homo- and hetero-dimer formation 57
Pituitary tumors: genetic and molecular factors underlying pathogenesis and clinical behavior 52
High Filamin a Expression in Adrenocortical Carcinomas Is Associated with a Favourable Tumour Behaviour: A European Multicentric Study 51
SCARB1 downregulation in adrenal insufficiency with Allgrove syndrome 48
Therapeutic potential of targeting the FLNA‐regulated Wee1 kinase in adrenocortical carcinomas 43
Filamin A is required for somatostatin receptor type 5 expression and pasireotide-mediated signaling in pituitary corticotroph tumor cells 43
USP8 inhibitor RA-9 reduces ACTH release and cell growth in tumor corticotrophs 35
A β-Arrestin 2-Biased Dopamine Receptor Type 2 (DRD2) Agonist Is More Efficacious Than Cabergoline in Reducing Cell Proliferation in PRL-Secreting but Not in Non-Functioning Pituitary Tumor Cells 30
Emerging role of IGF1R and IR expression and localisation in adrenocortical carcinomas 19
Therapeutic potential of targeting the FLNA-regulated Wee1 kinase in adrenocortical carcinomas 14
Dual inhibition of PLK1 and multiple CDKs: a novel approach for the treatment of adrenocortical carcinomas 1
Sphingosine kinase 1 inhibitor safingol as a new possible therapeutic strategy for adrenocortical carcinoma 1
Role of filamin A in the pathogenesis of neuroendocrine tumors and adrenal cancer 1
IGF2R: a new player in the insulin-like growth factor 2 (IGF2) pathway sustaining adrenocortical carcinoma cells growth 1
Totale 9.841
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.615
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.615
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202028 0 0 0 0 0 0 0 0 0 0 0 28
2020/2021975 50 39 93 20 76 68 80 74 150 122 146 57
2021/20221.502 55 39 83 148 178 161 164 127 188 109 46 204
2022/20231.162 138 133 92 133 129 201 22 84 114 14 53 49
2023/2024873 37 50 35 58 269 22 85 81 23 60 69 84
2024/20252.058 73 114 30 225 224 123 55 215 126 262 227 384
Totale 9.841